MedTrace Logo

A Multi-Dose Study With a Treatment for Open-Angle Glaucoma

NCT00705770 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2012-05-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether Anecortave Acetate is effective for lowering intraocular pressure caused by open-angle glaucoma.

Conditions

  • Open-Angle Glaucoma

Interventions

DRUG

Anecortave Acetate

Low dose Sustained release depot suspension

DRUG

Anecortave Acetate

Middle dose Sustained release depot suspension

DRUG

Anecortave Acetate

High dose Sustained release depot suspension

DRUG

Placebo

Placebo treatment with vehicle

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-07-31
Completion
2008-07-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00705770 on ClinicalTrials.gov